Documents & Downloads

Anti-MI/R injury agent 1

Anti-MI/R injury Agent

Anti-MI/R Injury Agent 1, a Panaxatriol derivative, serves as a potent therapeutic agent for myocardial ischemia/reperfusion (MI/R) injury. This compound significantly enhances cardiomyocyte viability following oxygen-glucose deprivation and reperfusion, making it a valuable tool for cardiovascular research. In preclinical studies, Anti-MI/R Injury Agent 1 has demonstrated the ability to reduce myocardial infarction size, decrease cardiac troponin I leakage, and mitigate cardiac tissue damage in rat models, highlighting its potential for protecting cardiac tissue in ischemic conditions.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2387506-35-4
Applications	Anti-MI/R injury Agent
Formula	C₃₂H₄₉NO₆
Molecular Weight	543.73
SMILES	CC1(C)C2=C(C(C(O)=O)=NO2)C[C@@]3(C)C1[C@@H](O)C[C@]4(C)C3C[C@@H](O)C5[C@@]4(C)CC[C@]5([H])[C@@]6(C)CCCC(C)(C)O6

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.